InvestorsHub Logo
Followers 10
Posts 3111
Boards Moderated 1
Alias Born 04/20/2001

Re: None

Thursday, 07/24/2014 11:39:09 AM

Thursday, July 24, 2014 11:39:09 AM

Post# of 120381
8:05 am Dr Pepper Snapple beats by $0.16, reports revs in-line; raises FY14 EPS, reaffirms FY14 revs guidance (DPS) : Reports Q2 (Jun) earnings of $1.06 per share, excluding non-recurring items, $0.16 better than the Capital IQ Consensus Estimate of $0.90; revenues rose 1.2% year/year to $1.63 bln vs the $1.62 bln consensus.


•For the quarter, reported net sales increased 1% as a sales volume increase, favorable product and package mix and pricing were partially offset by higher discounts and 1 percentage point of unfavorable foreign currency.
Co issues guidance for FY14, raises EPS to $3.43-3.51 from $3.38-3.46 vs. $3.47 Capital IQ Consensus; reaffrims FY14 revs flat to +1% to $6.0-6.06 bln vs. $6.05 bln Capital IQ Consensus Estimate. The company continues to expect full-year reported net sales to be flat to up 1%. The company is raising its guidance and now expects Core EPS to be in the $3.43 to $3.51 range. Packaging and ingredient costs, including LIFO impacts, are expected to decrease COGS by 2% on a constant volume/mix basis. The company expects its core tax rate to be approximately 35.5%. The company continues to expect capital spending to be ~3% of net sales. The company expects to repurchase $375 million to $400 million of its common stock.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.